PortfoliosLab logo
ACHC vs. EXAS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ACHC and EXAS is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ACHC vs. EXAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acadia Healthcare Company, Inc. (ACHC) and Exact Sciences Corporation (EXAS). The values are adjusted to include any dividend payments, if applicable.

0.00%500.00%1,000.00%1,500.00%2,000.00%December2025FebruaryMarchAprilMay
1,195.65%
244.20%
ACHC
EXAS

Key characteristics

Sharpe Ratio

ACHC:

-1.22

EXAS:

-0.08

Sortino Ratio

ACHC:

-1.91

EXAS:

0.01

Omega Ratio

ACHC:

0.72

EXAS:

1.00

Calmar Ratio

ACHC:

-0.84

EXAS:

-0.22

Martin Ratio

ACHC:

-1.53

EXAS:

-0.68

Ulcer Index

ACHC:

42.35%

EXAS:

23.55%

Daily Std Dev

ACHC:

54.77%

EXAS:

59.71%

Max Drawdown

ACHC:

-98.67%

EXAS:

-98.01%

Current Drawdown

ACHC:

-73.23%

EXAS:

-66.69%

Fundamentals

Market Cap

ACHC:

$2.20B

EXAS:

$9.74B

EPS

ACHC:

$2.78

EXAS:

-$5.53

PEG Ratio

ACHC:

1.32

EXAS:

-1.07

PS Ratio

ACHC:

0.71

EXAS:

3.44

PB Ratio

ACHC:

0.72

EXAS:

4.19

Total Revenue (TTM)

ACHC:

$2.39B

EXAS:

$2.83B

Gross Profit (TTM)

ACHC:

$1.72B

EXAS:

$1.93B

EBITDA (TTM)

ACHC:

$445.44M

EXAS:

-$848.74M

Returns By Period

In the year-to-date period, ACHC achieves a -39.87% return, which is significantly lower than EXAS's -8.12% return. Over the past 10 years, ACHC has underperformed EXAS with an annualized return of -9.89%, while EXAS has yielded a comparatively higher 8.48% annualized return.


ACHC

YTD

-39.87%

1M

-18.08%

6M

-41.60%

1Y

-66.18%

5Y*

-2.14%

10Y*

-9.89%

EXAS

YTD

-8.12%

1M

13.47%

6M

0.29%

1Y

-4.65%

5Y*

-8.86%

10Y*

8.48%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ACHC vs. EXAS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACHC
The Risk-Adjusted Performance Rank of ACHC is 33
Overall Rank
The Sharpe Ratio Rank of ACHC is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of ACHC is 33
Sortino Ratio Rank
The Omega Ratio Rank of ACHC is 22
Omega Ratio Rank
The Calmar Ratio Rank of ACHC is 44
Calmar Ratio Rank
The Martin Ratio Rank of ACHC is 66
Martin Ratio Rank

EXAS
The Risk-Adjusted Performance Rank of EXAS is 3939
Overall Rank
The Sharpe Ratio Rank of EXAS is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of EXAS is 3737
Sortino Ratio Rank
The Omega Ratio Rank of EXAS is 3737
Omega Ratio Rank
The Calmar Ratio Rank of EXAS is 3838
Calmar Ratio Rank
The Martin Ratio Rank of EXAS is 3737
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ACHC vs. EXAS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Acadia Healthcare Company, Inc. (ACHC) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ACHC Sharpe Ratio is -1.22, which is lower than the EXAS Sharpe Ratio of -0.08. The chart below compares the historical Sharpe Ratios of ACHC and EXAS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.20-1.00-0.80-0.60-0.40-0.200.00December2025FebruaryMarchAprilMay
-1.22
-0.08
ACHC
EXAS

Dividends

ACHC vs. EXAS - Dividend Comparison

Neither ACHC nor EXAS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ACHC vs. EXAS - Drawdown Comparison

The maximum ACHC drawdown since its inception was -98.67%, roughly equal to the maximum EXAS drawdown of -98.01%. Use the drawdown chart below to compare losses from any high point for ACHC and EXAS. For additional features, visit the drawdowns tool.


-75.00%-70.00%-65.00%-60.00%-55.00%-50.00%December2025FebruaryMarchAprilMay
-73.23%
-66.69%
ACHC
EXAS

Volatility

ACHC vs. EXAS - Volatility Comparison

Acadia Healthcare Company, Inc. (ACHC) has a higher volatility of 18.44% compared to Exact Sciences Corporation (EXAS) at 13.56%. This indicates that ACHC's price experiences larger fluctuations and is considered to be riskier than EXAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
18.44%
13.56%
ACHC
EXAS

Financials

ACHC vs. EXAS - Financials Comparison

This section allows you to compare key financial metrics between Acadia Healthcare Company, Inc. and Exact Sciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


300.00M400.00M500.00M600.00M700.00M800.00M20212022202320242025
774.24M
706.79M
(ACHC) Total Revenue
(EXAS) Total Revenue
Values in USD except per share items

ACHC vs. EXAS - Profitability Comparison

The chart below illustrates the profitability comparison between Acadia Healthcare Company, Inc. and Exact Sciences Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
96.3%
70.8%
(ACHC) Gross Margin
(EXAS) Gross Margin
ACHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported a gross profit of 745.68M and revenue of 774.24M. Therefore, the gross margin over that period was 96.3%.

EXAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a gross profit of 500.55M and revenue of 706.79M. Therefore, the gross margin over that period was 70.8%.

ACHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported an operating income of 103.46M and revenue of 774.24M, resulting in an operating margin of 13.4%.

EXAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported an operating income of -96.01M and revenue of 706.79M, resulting in an operating margin of -13.6%.

ACHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported a net income of 32.62M and revenue of 774.24M, resulting in a net margin of 4.2%.

EXAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a net income of -101.22M and revenue of 706.79M, resulting in a net margin of -14.3%.